TransCode Therapeutics Inc (RNAZ)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -595.098 | -372.359 | -57.042 | -115.082 | -290.735 |
Return on Equity (%) | 109.369 | 103.763 | -80.525 | -148.573 | -759.771 |
Return on Invested Capital (%) | 816.071 | 99.045 | -64.577 | -157.877 | -814.172 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.145 | -0.446 | 1.581 | 0.25 | 0.082 |
Earnings Per Share | -0.079 | -0.307 | -0.53 | -1.354 | -0.923 |
Cash Per Share | 0.027 | 0.108 | 1.614 | 0.383 | 0.138 |
Working Capital Per Share | 0.018 | 0.056 | 1.565 | 0.234 | 0.048 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.079 | -0.307 | -0.53 | -1.354 | -0.923 |
EBITDA Per Share | -0.079 | -0.307 | -0.53 | -1.354 | -0.923 |
Free Cash Flow Per Share | -0.079 | -0.307 | -0.514 | -1.353 | -0.927 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 7,64M | 7,64M | 12,91M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,35M |
Ratio cours/bénéfice | -0,13 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,87 |
Ratio prix/valeur comptable | 1,46 |
Rendement de dividende | - |
Actions en circulation | 696,23k |
Volume moyen (1 semaine) | 108,54k |
Volume moyen (1 mois) | 103,62k |
Variation sur 52 semaines | -98,38% |
Plus haut sur 52 semaines | 236,94 |
Plus bas sur 52 semaines | 3,21 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales